Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06709456

Drainage Of Pleural Effusions in the Intensive Care Unit (DOPE-ICU) - Feasibility Trial

Led by Olav Schjørring · Updated on 2025-04-11

88

Participants Needed

6

Research Sites

43 weeks

Total Duration

On this page

Sponsors

O

Olav Schjørring

Lead Sponsor

R

Rigshospitalet, Denmark

Collaborating Sponsor

AI-Summary

What this Trial Is About

This trial evaluates the feasibility of ultrasound-guided pleural drainage versus no drainage in adult ICU patients with pleural effusions (fluid buildup around the lungs) and respiratory failure. Half of the patients will undergo drainage, while the other half will not unless their condition worsens to a prespecified degree. Outcomes include feasibility measures, clinical parameters, mortality, serious adverse events, and life support use over 90 days.

CONDITIONS

Official Title

Drainage Of Pleural Effusions in the Intensive Care Unit (DOPE-ICU) - Feasibility Trial

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Acute admission to the ICU
  • Age 18 years or older
  • Pleural effusion of 2 cm or more in either pleural cavity measured by ultrasound, CT, or MRI
  • Respiratory failure defined by oxygen supplementation, mechanical ventilation, or recent arterial blood gas with PaCO2 > 6.0 kPa and pH < 7.35
Not Eligible

You will not qualify if you...

  • Presence of mediastinal or pleural drain on either side
  • Suspected or confirmed haemothorax
  • Suspected or confirmed pneumothorax
  • Suspected or confirmed pleural empyema
  • Pleural malignancy such as lymphoma, metastases, or mesothelioma
  • Antithrombotic treatment or coagulation issues preventing drainage
  • Absolute indication for therapeutic drainage with severe respiratory failure or acidosis despite ventilation
  • Withdrawal from active therapy or imminent brain death
  • Expected ICU stay less than 24 hours from randomisation
  • Pregnancy in females under 60 years unless confirmed negative by tests or incompatible condition
  • Under coercive measures or involuntary admission
  • Consent cannot be obtained according to Danish law
  • Previously participated in this trial

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

Department of Anaesthesia and Intensive Care, Aalborg University Hospital

Aalborg, Denmark, 9000

Actively Recruiting

2

ICU department 4131, Copenhagen University Hospital, Rigshospitalet

Copenhagen, Denmark, 2100

Actively Recruiting

3

Department of Anaesthesia and Intensive Care, Nordsjællands Hospital, University of Copenhagen, Hillerød

Hillerød, Denmark, 3400

Actively Recruiting

4

Department of Anaesthesiology and Intensive Care Medicine, Sygehus Lillebælt, Kolding

Kolding, Denmark, 6000

Actively Recruiting

5

Department of Anaesthesia and Intensive Care, Zealand University Hospital, Køge

Køge, Denmark, 4600

Not Yet Recruiting

6

Department of Anaesthesia and Intensive Care, Zealand University Hospital, Roskilde

Roskilde, Denmark, 4000

Not Yet Recruiting

Loading map...

Research Team

M

Marie S Worm, MD

CONTACT

O

Olav L Schjørring, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here